Incyte Corporation · NASDAQ:INCY
Mayes Patrick A sold 47,954 Incyte Corporation shares (Form 4)
Traded Jul 31 to Aug 3, 2026 · Filed Aug 4, 2026
From Jul 31 to Aug 3, 2026, Mayes Patrick A (EVP & Chief Scientific Officer) sold 47,954 Incyte Corporation shares at an average US$119.58 for US$5.73M under a trading plan, leaving 61,441 shares. Filed Aug 4, 2026 (Form 4).
- Sold
- 47,954 shares
- Price
- US$119.58 average (US$119.38 to US$122.19)
- Value
- US$5.73M
- Holding after
- 61,441 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP & Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 31, 2026 | Common Stock | Option exercise | 2,918 | US$61.18 | 66,546 | Direct |
| Jul 31, 2026 | Common Stock | Option exercise | 2,284 | US$64.25 | 68,830 | Direct |
| Jul 31, 2026 | Common Stock | Option exercise | 2,709 | US$61.76 | 71,539 | Direct |
| Jul 31, 2026 | Common Stock | Option exercise | 3,148 | US$68.62 | 74,687 | Direct |
| Jul 31, 2026 | Common Stock | Option exercise | 2,072 | US$71.93 | 76,759 | Direct |
| Jul 31, 2026 | Common Stock | Option exercise | 9,459 | US$72.27 | 86,218 | Direct |
| Jul 31, 2026 | Common Stock | Option exercise | 2,623 | US$74.78 | 88,841 | Direct |
| Jul 31, 2026 | Common Stock | Option exercise | 2,864 | US$77.67 | 91,705 | Direct |
| Jul 31, 2026 | Common Stock | Option exercise | 1,643 | US$80.50 | 93,348 | Direct |
| Jul 31, 2026 | Common Stock | Option exercise | 3,023 | US$83.20 | 96,371 | Direct |
| Jul 31, 2026 | Common Stock | Option exercise | 2,623 | US$83.58 | 98,994 | Direct |
| Jul 31, 2026 | Common Stock | Option exercise | 1,642 | US$85.01 | 100,636 | Direct |
| Jul 31, 2026 | Common Stock | Option exercise | 2,293 | US$90.56 | 102,929 | Direct |
| Jul 31, 2026 | Common Stock | Option exercise | 85 | US$106.47 | 103,014 | Direct |
| Jul 31, 2026 | Common Stock | Option exercise | 326 | US$105.43 | 103,340 | Direct |
| Jul 31, 2026 | Common Stock | Sale | 14,661 | US$119.46 | 88,679 | Direct |
| Jul 31, 2026 | Common Stock | Sale | 5,332 | US$119.42 | 83,347 | Direct |
| Jul 31, 2026 | Common Stock | Sale | 2,187 | US$119.47 | 81,160 | Direct |
| Jul 31, 2026 | Common Stock | Sale | 6,171 | US$119.43 | 74,989 | Direct |
| Jul 31, 2026 | Common Stock | Sale | 4,695 | US$119.39 | 70,294 | Direct |
| Jul 31, 2026 | Common Stock | Sale | 2,864 | US$119.40 | 67,430 | Direct |
| Jul 31, 2026 | Common Stock | Sale | 1,643 | US$119.51 | 65,787 | Direct |
| Jul 31, 2026 | Common Stock | Sale | 1,642 | US$119.38 | 64,145 | Direct |
| Jul 31, 2026 | Common Stock | Sale | 85 | US$122.19 | 64,060 | Direct |
| Jul 31, 2026 | Common Stock | Sale | 326 | US$121.69 | 63,734 | Direct |
| Jul 31, 2026 | Common Stock | Sale | 2,293 | US$119.41 | 61,441 | Direct |
| Aug 3, 2026 | Common Stock | Option exercise | 6,055 | US$105.43 | 67,496 | Direct |
| Aug 3, 2026 | Common Stock | Sale | 6,055 | US$120.43 | 61,441 | Direct |
Source
Related
- Incyte Corporation
- Mayes Patrick A
- Incyte Corporation shareholders
- Form 4 · Mayes Patrick A · Aug 7, 2026
- Form 4 · Mayes Patrick A · Jul 20, 2026
- Form 4 · Mayes Patrick A · Jul 16, 2026
- Form 4 · Mayes Patrick A · Jul 7, 2026
- Form 4 · Cagnoni Pablo J · Oct 19, 2026
- Form 4 · Heeson Lee · Oct 5, 2026
- Form 4 · Baker Bros. Advisors LP · Oct 2, 2026
- Form 4 · Clancy Paul J · Oct 2, 2026
- Form 4 · Harrigan Edmund · Oct 2, 2026